23 hrs ago | SouthCoastToday.com
Human growth hormone is not for healthy people
DEAR DR. DONOHUE: I am thinking about using human growth hormone-releasing hormone pills.
Pfizer By American Technology Research WE ARE INITIATING COVERAGE of Pfizer with a Buy rating.
Reuters
|
Reuters
Omega-3 fatty acid may stop repeat stroke
By Scott Baltic
NEW YORK (Reuters Health) - Eicosapentaenoic acid, or EPA -- the essential omega-3 polyunsaturated fatty acid abundant in oily fish -- may help protect stroke patients from suffering a second stroke, a Japanese study shows.
In a study of people with high cholesterol who were taking a low dose of a cholesterol-lowering "statin," researchers found that adding EPA did not reduce the occurrence of a first stroke but did lower recurrence rates in those with a history of stroke.
Statins have unexpected effect on pool of powerful brain cells
Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University of Rochester Medical Center have found.
Healthy, tasty July Fourth treats
Nothing is as refreshing as ice cream on a hot summer day. The following recipes use healthful and tasty ingredients to make your own nutritious frozen treats for your July Fourth celebration.
Low Levels Of Good Cholesterol Linked To Memory Loss, Dementia Risk
Low levels of high-density lipoproteins -- the "good" cholesterol -- in middle age may increase the risk of memory loss and lead to dementia later in life, researchers reported in Arteriosclerosis, Thrombosis ...
Trends in total cholesterol screening and in prescribing...
General Practitioners play a central role in controlling an important risk factor for cardiovascular diseases, i.e. cholesterol levels in serum.
Good Cholesterol Linked to Memory; Lack of HDL May Raise Risk of Dementia
The good cholesterol that removes fatty plaque from the body may also be linked to memory, and low levels may indicate a risk for dementia, a British study found.
Pfizer And Ranbaxy Settle Lipitor Patent Litigation Worldwide
Main Category: Hypertension Also Included In: Cholesterol Article Date: 23 Jun 2008 - 2:00 PDT Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd.
Spending On Cholesterol Reducing Statins More Than Doubles In Just Five Years, USA
Spending on statins, drugs used to reduce artery-clogging cholesterol, increased 156 percent between 2000 and 2005, according to the latest News and Numbers from the federal Agency for Healthcare Research and ...
Study shows 150 percent jump in statin use
WASHINGTON - Use of cholesterol-lowering drugs called statins rose by 156 percent between 2000 and 2005, with spending jumping from $7.7 billion to $19.7 billion, the U.S. Agency for Healthcare Research and ...
Stretching your healthcare dollars
As Canada's population ages, more and more people will incur costs for medication and other products and services to keep themselves healthy.
Walgreens prescribes more club card use
Walgreens is getting more aggressive about marketing its prescription savings club card in a tough economy with cut-throat competition for cheap generics.
Another option for high cholesterol
I'm sure you've heard of 'statins' like Lipitor , Zocor , and Pravachol . These powerful cholesterol-lowering medicines are widely used some people make jokes about adding them to the water supply.
Controling Risk Factors Reduces Risk of Stroke by 42 Percent
Results of a new analysis of the Treating to New Targets study show that intensive low-density lipoprotein cholesterol-lowering in patients with stable coronary heart disease whose systolic blood pressure was ...
Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER...
Jun 20, 2008 - Merck & Co., Inc. today provided an update on the regulatory status in the United States of its investigational medicines MK-0524A and MK-0524B for the treatment of primary hypercholesterolemia ...
Gene Variation May Block Cholesterol Drugs
A gene variation may be why cholesterol-lowering drugs dont work in some people.
Ranbaxy, Pfizer scrips fall after Lipitor deal
Concerns that neither Pfizer nor Ranbaxy might have got a better deal than the other depressed investor confidence that took a toll on the stock prices of the two companies on their respective stock exchanges.
Study helps explain wide response to statins
Differences in the way people process genetic information may explain why some get a huge benefit from cholesterol-fighting drugs known as statins, while others get very little, U.S. researchers said on Monday.
Sanofi-Aventis bids $2.6 billion for generic maker
Sanofi-Aventis' offer for Zentiva , which is based in the Czech republic, comes as the big drugmaker struggles with the usual twin problems afflicting pharma - thinning pipelines and expiring patents.
Sponsored links